Role of Corticotropin-Releasing Factor (CRF) Receptors in the Anorexic Syndrome Induced by CRF
2000
Genetic manipulations of corticotropin-
releasing factor(
CRF) 1 and
CRF2 receptors have resulted in data suggesting that the
CRF2 receptor could mediate the effects of
CRFon
appetiteor satiety. We have attempted to obtain pharmacological evidence for this hypothesis by comparing the ability of a high-affinity peptide, mixed
CRFantagonist [cyclo 30-33,f12,L18,21E30, A32,K33]
suckerfish
urotensin(12-41)NH 2 [cUTSN (12-41)] with a small-molecule
CRF1 -selective antagonist, NBI-27914, and a
CRF2 -selective peptide antagonist, antisauvagine-30, to attenuate the anorexic effects of
CRF. We also monitored other behaviors that accompanied
CRF-induced
anorexia.
CRF-induced
anorexiawas significantly correlated with a reduction in locomotor activity and an increase in
freezing behaviorand
piloerection. cUTSN (12-41) and antisauvagine-30 significantly attenuated the effects of
CRF(0.04 nmol) on food intake along with the
behavioral syndromethat accompanied
anorexia. In contrast, NBI-27914 did not attenuate either of the above-mentioned
CRF-induced phenomena when given centrally at doses ranging from 0.13 to 10 nmol/2.5 μl or when given orally at 20 to 40 mg/kg. Although these data support the hypothesis that the
CRF2 receptor mediates the
appetitesuppression induced by
CRF, they also suggest that the
CRF2 receptor could mediate the stress-like behaviors that accompany
CRF-induced
appetitesuppression.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
41
References
140
Citations
NaN
KQI